NCT06631339

Brief Summary

The goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance in children. This trial has 3 arms namely, (1) a technical intervention arm, (2) a digital intervention arm, and (3) a control arm.

  • be randomised to receive either no intervention (control group), technical intervention (light intervention that mimics sunlight) or digital intervention (parents having an app that syncs with child's light and activity sensor which will provide feedback to parents to encourage and recommends increment of outdoor activities and hours).
  • have their myopia progression monitored every 6 monthly and cognitive assessment done once every 3 months over a year.
  • wear the light and activity sensor watches throughout the 1-year study period as much as possible (minimum 1 week per month) except for wet water activities such as swimming, diving and showering for research data collection purpose.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
396

participants targeted

Target at P75+ for not_applicable

Timeline
9mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Oct 2024Jan 2027

First Submitted

Initial submission to the registry

October 1, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

October 21, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2027

Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

2.3 years

First QC Date

October 1, 2024

Last Update Submit

September 21, 2025

Conditions

Keywords

Light ExposureDigital InterventionMyopiaMyopia PreventionCognitionLight InterventionBehaviour changing phone applicationClassroomSchool-basedSchoolSingaporePrimary SchoolLight therapyMyopia-control

Outcome Measures

Primary Outcomes (3)

  • Cycloplegic auto-refraction

    Measured using autoref/kerato/pachy/tonometer

    1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  • Axial Length

    Measured using non-contact optical biometer

    1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  • Choroidal Thickness

    Measured using optical coherence tomography (OCT) scan

    1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Secondary Outcomes (13)

  • Retinal and choroidal perfusion

    1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  • Corneal Curvature

    1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  • Corneal Thickness

    1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

  • Impulse control

    1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

  • Cognitive flexibility

    1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

  • +8 more secondary outcomes

Other Outcomes (6)

  • Daytime average light levels (lux)

    1 year or at least 1 week per month for 1 year

  • Daytime average melanopic lux

    1 year or at least 1 week per month for 1 year

  • Time spent outdoors (questionnaires)

    1 year or at least 1 week per month for 1 year

  • +3 more other outcomes

Study Arms (3)

Technical Intervention (n=132)

EXPERIMENTAL

Technical refinement of classroom lighting + Sham LightUP phone application (s-LightUP)

Other: Light Intervention

Digital Intervention (n=132)

EXPERIMENTAL

Standard classroom lighting + Interventional LightUP phone application (i-LightUP)

Behavioral: Digital Intervention

Control Group (n=132)

PLACEBO COMPARATOR

Standard care or control group which involves standard classroom lighting + Sham LightUP app (s-LightUP).

Other: Control Group

Interventions

LEDs mimicking the spectrum of sunlight (4000K) administered daily for 1 academic year, every school day, for the entire school day. The light levels generated by these LEDs will fluctuate throughout the day but will remain under 1000 lux.

Technical Intervention (n=132)

Smart-phone application (LightUP) will be synced daily to a child-worn light and activity sensor and will allow parents to track their children's outdoor time and exposure to brighter light levels across the day. The application will also nudge parents to increase their child's exposure to light (e.g., increase time outdoors, or sitting next to a window indoors) after school hours for better myopia prevention and control. i-LightUP aims to gradually assist parents in helping their children reach the ultimate goal of spending at least 2 hours per day in brighter light conditions (e.g., above 1000 lux).

Digital Intervention (n=132)

Standard Classroom Lighting + Sham LightUP phone application

Control Group (n=132)

Eligibility Criteria

Age7 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Written Informed Consent form from parent / legal guardian and assent from child subject has been obtained
  • Is between 7 to 10 years of age at start of study intervention which is 2 January 2025 or 1 January 2026
  • Studying in either Primary 2 or 3 classes of the participating school(s) in academic year 2025 or 2026.
  • Presenting visual acuity or best corrected visual acuity (BCVA) better or equal to LogMAR 0.2 (equivalent to Snellen 6/9 or better) in each eye
  • Normal Intraocular pressure (not more than 21mmHg)
  • No ocular conditions (e.g., optic nerve disease, glaucoma, retinal diseases) except for refractive error.
  • No ocular conditions affecting the accuracy of the ophthalmic examinations
  • In good general health with no significant systemic diseases that may affect eye health

You may not qualify if:

  • Previous or ongoing myopia control treatment (including but not limited to orthokeratology, atropine, pirenzepine, myopia control spectacle and contact lenses, light therapy)
  • Ongoing participation in other myopia prevention and control research trials
  • Any systemic or neurologic diseases (e.g. cancer, epilepsy, Kawasaki disease) known to affect eye health or make the participant vulnerable to the ophthalmic examinations (e.g., light flash)
  • Any other conditions precluding adherence to the protocol including unwillingness to refrain from myopia control treatment for the duration of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

National University of Singapore, Yong Loo Lin School of Medicine, Department of Ophthalmology, Eye N Brain Research Lab

Singapore, 119276, Singapore

RECRUITING

Marymount Convent School

Singapore, 297754, Singapore

RECRUITING

Bedok Green Primary School

Singapore, 469317, Singapore

RECRUITING

Westwood Primary School

Singapore, 649188, Singapore

RECRUITING

Wellington Primary School

Singapore, 757702, Singapore

RECRUITING

MeSH Terms

Conditions

MyopiaRefractive Errors

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Raymond P. Najjar, PhD

    National University of Singapore

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Raymond P. Najjar, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
This study is a double-blind, semi-randomised controlled trial in which neither the study participants, the investigators nor study personnel responsible for measuring and analysing the study outcomes will be aware of the treatment given. Study team will document consent to participate and non-objection response to classroom lighting change. A 100% non-objection rate from the parents of students within one classroom will be required prior to changing the classroom lighting. Randomization: Classrooms randomly be assigned into technical or other arms (cluster). Students from classrooms not included in the technical arms will be randomized into control or digital intervention arm. For the purpose of maintaining double-blind, all participants (parents) will be given LightUP application that will either be sham or interventional. Only a group of unmasked study personnel will know the treatment allocation and they will not be involved in data collection and analysis of results/data.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Primary School-based, 12-Month, semi-randomised, controlled, double-blinded, 3 study arm (n=132 per arm) trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 1, 2024

First Posted

October 8, 2024

Study Start

October 21, 2024

Primary Completion (Estimated)

January 26, 2027

Study Completion (Estimated)

January 26, 2027

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations